glp 1 drugs best for weight loss List of approved and pending GLP-1 medications Patients' Use GLP-1 Drugs for

Current recommendations from the American Society for Metabolic and Bariatric Surgery and the Endocrine Society support considering these agents as part of comprehensive management when lifestyle modifications prove insufficient and specific clinical criteria are met

The gut microbiota was analyzed in fecal samples collected in sterile containers one or two days before each visit

Many report that they were prescribed the drug for weight loss and were never warned about the risk of severe complications

Data extraction Two designated authors (AM and SS) meticulously extracted pertinent data from the included studies, including authorship details, publication timeline, samples of the study, mean demographic parameters (e.g., age, sex, baseline weight, and baseline BMI), type of bariatric surgery, prevalent background diseases, type of the GLP-1RAs therapy, the time of the initiation of the medical treatment, laboratory indices, amount of weight-change, and a comprehensive array of outcome measures, such as nausea, vomiting, diarrhea, and serious adverse events

To report suspected adverse reactions to compounded GLP-1s, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch